Komori
Share Issuance and Disposal4078Sakai Chemical Industry Co.,Ltd.Materials and Chemicals

Notice Regarding Completion of Exercise of the 4th Series of Stock Acquisition Rights and Issuance of New Shares

All of the fourth series of stock acquisition rights issued in 2023 were exercised, and the company plans to issue 1,012,600 new shares. This will raise approximately ¥2 billion, leaving no unexercised stock acquisition rights.

Worth reading
82Important
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
1012600
Shares
Wording
Conditional
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares upon exercise of the fourth series of stock acquisition rights

Who receives how much1,012,600Shares

1,012,600 shares (new shares)

SH1, L.P.

The lower thin line represents the existing number of shares to which these shares will be added.

¥1,975 per share
Total issue value

¥1,999,885,000

Amount of funds to be raised
Total payment amount: ¥1,999,885,000; estimated net proceeds: Not disclosed
Specific use of funds
Funds reserved for M&A. Planned for allocation to M&A aimed at expanding the business, primarily in growth businesses.Amount ¥1,999,885,000 / Scheduled timing of expenditures Through the exercise deadline applicable when the stock acquisition rights were issued (the end of December 2027)
If the funds cannot be allocated to M&A or an unused balance remains, the company will also consider allocating them to research and development investment and investment in new businesses.Scheduled timing of expenditures If the funds cannot be allocated to M&A by the end of December 2027 or an unused balance remains
Existing Shares and Increase
+5.78%Rate of increase
17,518,987 shares18,531,587Shares

5.78% (1,012,600 shares ÷ 17,518,987 shares)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
¥1,975 per share. Adjustment provisions and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 10,126 units; unexercised: 0 units
Most recent equity financing
Timing June 2023 / Type Fourth series of unsecured convertible bonds with stock acquisition rights and fourth series of stock acquisition rights, issued through a third-party allotment / Amount Not disclosed
Impact on Business Performance
The total number of issued shares will increase upon exercise of these stock acquisition rights, but the company does not plan to revise its dividend forecast of ¥160.00 per share for the annual dividend announced on 7 August 2026.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares upon exercise of the fourth series of stock acquisition rights
Number of shares to be issued or disposed of1,012,600 shares (new shares)
Issue price and disposal price¥1,975 per share
Total issue value¥1,999,885,000
Amount of funds to be raisedTotal payment amount: ¥1,999,885,000; estimated net proceeds: Not disclosed
Specific use of fundsDetails Funds reserved for M&A. Planned for allocation to M&A aimed at expanding the business, primarily in growth businesses. / Amount ¥1,999,885,000 / Scheduled timing of expenditures Through the exercise deadline applicable when the stock acquisition rights were issued (the end of December 2027), Details If the funds cannot be allocated to M&A or an unused balance remains, the company will also consider allocating them to research and development investment and investment in new businesses. / Amount Not disclosed / Scheduled timing of expenditures If the funds cannot be allocated to M&A by the end of December 2027 or an unused balance remains
Intended allotteeSH1, L.P.
Dilution Rate5.78% (1,012,600 shares ÷ 17,518,987 shares)
Total number of issued shares17,518,987 shares → 18,531,587 shares(5.78%)
Exercise price¥1,975 per share. Adjustment provisions and adjustment floor: Not disclosed
Number of Stock Acquisition RightsTotal issued: 10,126 units; unexercised: 0 units
Most recent equity financingTiming June 2023 / Type Fourth series of unsecured convertible bonds with stock acquisition rights and fourth series of stock acquisition rights, issued through a third-party allotment / Amount Not disclosed
Impact on Business PerformanceThe total number of issued shares will increase upon exercise of these stock acquisition rights, but the company does not plan to revise its dividend forecast of ¥160.00 per share for the annual dividend announced on 7 August 2026.
Items this document does not state (15)
Estimated issuance expensesPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company explained that it plans to reserve the funds raised for M&A aimed at expanding its business, primarily in growth businesses. If the funds cannot be used for M&A or an unused balance remains, the company will also consider allocating them to research and development investment and investment in new businesses.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Completion of Exercise of the 4th Series of Stock Acquisition Rights and Issuance of New Shares | Sakai Chemical Industry Co.,Ltd. (4078) timely disclosure | Komori